CTOs on the Move

Edmund Optics

www.edmundoptics.com

 
Edmund Optics (EO) has been a leading supplier of precision optics and optical components since 1942, designing and manufacturing a wide array of multi-element optical lenses, lens coatings, imaging systems, and optomechanical equipment. Led by a staff of skilled optical engineers and scientists, EO is application focused and pursues new ways to implement optical technology, enabling advancements in industrial metrology, semiconductor manufacturing, life sciences, and more. EO is a worldwide presence in industrial optics extending well beyond our original manufacturing plant and corporate headquarters in Barrington, New Jersey, USA.
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details
Melanie Matheu
CTO Profile
Ekaterina Golovchenko
Senior Vice President of Technology and Development Profile

Similar Companies

Reliance Health Care Mgmt.

Reliance Health Care Mgmt., Inc. is a Conway, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aliron International

Aliron International is a Bethesda, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Pill Club

The Pill Club is the first all-in-one healthcare startup delivering and prescribing birth control across the US.

Interior Health

With the help of our staff and physicians, Interior Health is proud to deliver high-quality health-care services to the communities and visitors of the Southern Interior of British Columbia. We strive to set new standards of excellence in the delivery of health services in the province of B.C. and our mission is to promote healthy lifestyles and provide needed health services in a timely, caring and efficient manner, to the highest professional and quality standards.

Integrated Diagnostics

At Indi we believe that a systems-based approach is necessary to understand complex diseases and improve health. Our mission is to dramatically improve diagnosis and management of complex diseases by building advanced molecular diagnostics and creating new diagnostic technologies. We seek to understand the complex biological systems from which diseases arise so that we can determine which combinations of biomarkers have the greatest diagnostic power. Then we build assays capable of measuring hundreds of proteins at a time, for more precise detection and management of disease. Our end goal is to create large-scale systems medicine diagnostics that can gather a wealth of information – and then make sense of that information so that physicians can better diagnose disease.